SCHEMBL29005252

SCHEMBL29005252

CON(C)C(=O)c1ccc(OCC(F)(F)F)nn1

nearest known ligand 0.43

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.43
MLYCD O95822 1/20 0.39
NNMT P40261 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
SCN9A Q15858 7/20 0.37
IL1B P01584 1/20 0.36
CNR2 P34972 1/20 0.36
POLB P06746 1/20 0.35
MAPK1 P28482 1/20 0.35
GABRA1 P14867 1/20 0.35
MAPT P10636 2/20 0.34
HCRTR1 O43613 1/20 0.34
HCRTR2 O43614 1/20 0.34
SCN10A Q9Y5Y9 1/20 0.34
HDAC4 P56524 1/20 0.33
HDAC6 Q9UBN7 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30342225 1.00 L3MBTL1 (0.43) L3MBTL1MLYCDNNMTSMN1; SMN2SCN9A
SCHEMBL15350216 0.83 L3MBTL1 (0.47) L3MBTL1NNMTSMN1; SMN2IL1BCNR2
SCHEMBL2712958 0.80 CNR2 (0.42) L3MBTL1MLYCDSCN9ACNR2POLB
SCHEMBL29005276 0.80 L3MBTL1 (0.43) L3MBTL1MLYCDSCN9ACNR2POLB
SCHEMBL30342136 0.80 L3MBTL1 (0.43) L3MBTL1MLYCDSCN9ACNR2POLB
SCHEMBL2713528 0.78 L3MBTL1 (0.63) L3MBTL1MLYCDSCN9APOLBMAPK1
SCHEMBL31191212 0.78 CNR2 (0.37) L3MBTL1MLYCDSCN9ACNR2HCRTR1
SCHEMBL458005 0.78 L3MBTL1 (0.58) L3MBTL1NNMTSMN1; SMN2SCN9AIL1B
SCHEMBL29990185 0.76 CNR2 (0.45) MLYCDSCN9ACNR2HCRTR1HCRTR2
SCHEMBL15350909 0.76 CNR2 (0.40) L3MBTL1MLYCDCNR2GABRA1HCRTR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116134018-A 2-oxoimidazolidine-4-carboxamide as NAV1.8 inhibitor 默沙东有限责任公司 2023-05-16 CN disclosed
CN-116056697-A 2-oxo-oxazolidine-5-carboxamides as NAV1.8 inhibitors 默沙东有限责任公司 2023-05-02 CN disclosed